Amlodipine Completed Phase 3 Trials for acute iron intoxication / Thalassaemic disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01395199Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major